Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masazumi Matsumura is active.

Publication


Featured researches published by Masazumi Matsumura.


Journal of Pharmaceutical Sciences | 2010

Characterization of antibody aggregation: Role of buried, unpaired cysteines in particle formation

Stephen R. Brych; Yatin R. Gokarn; Heather Hultgen; Riki Stevenson; Rahul S. Rajan; Masazumi Matsumura

Proteins are susceptible to degradation upon exposure to a variety of stresses during product manufacturing, transportation and storage. In this study, we investigated the aggregation properties of a monoclonal antibody during agitation stress. Agitation exclusively led to insoluble aggregates, or particle formation. Removal or modification of the air-liquid interface with a surfactant (e.g., polysorbate) abrogated particle formation. The supernatant postagitation was analyzed using SE-HPLC, FTIR, and AUC analyses and revealed no changes in conformation and aggregation profile when compared to the nonagitated antibody sample. The antibody particles were comprised of a combination of nonnative intermolecular disulfide-linked covalent as well as noncovalent interactions. Analysis of the antibodys unpaired cysteines revealed that the nonnative intermolecular disulfide bonds were formed through buried cysteines, which suggested at least partial unfolding of the antibody domains. FTIR analysis indicated that the particulated antibody maintained significant native-like secondary structure suggesting that particle formation led to minimal structure changes, but capable of exposing free cysteines to solvent to form the nonnative intermolecular disulfide bonds. The results presented in this study indicate the importance of the interactions between the antibody and the air-liquid interface during agitation in the formation of particles and suggests that reduced disulfide bonds may play a significant role in the particulation reaction. This phenomenon can be applicable to other proteins with similar free cysteine and structural characteristics.


Journal of Pharmaceutical Sciences | 2009

Elucidation of Two Major Aggregation Pathways in an IgG2 Antibody

Nicholas Van Buren; Douglas Rehder; Himanshu S. Gadgil; Masazumi Matsumura; Jaby Jacob

Two major aggregation pathways observed in an IgG2 molecule are described. Different aggregate species generated by long-term incubation of the antibody at 37 degrees C were collected by a semi-preparative size exclusion chromatography method. These purified species were analyzed extensively by denaturing size-exclusion chromatography methods. The major aggregation pathway at low pH (4.0) resulted in the formation of both dimers and high molecular weight (HMW) aggregates. It was found that these dimers and HMW aggregates contain antibody molecules that have a peptide bond cleavage between an aspartic acid and proline residue in the CH2 domain. Evidence that unfolding of the CH2 domain may be driving the aggregation at low pH is presented. At higher pH (pH - 6.0), formation of a dimer having approximately 75% covalent character was the major aggregation pathway while formation of higher molecular weight aggregates were largely suppressed. The covalent dimer consisted of both disulfide linked antibody molecules and another species (approximately 26%) that was formed due to nondisulfide covalent bonds between two heavy chains. At pH - 5.0, both dimer and higher molecular weight aggregates were formed and the aggregation pathway was a combination of the major pathways observed at pH - 4.0 and 6.0. The dimer species formed at pH - 5.0 had a larger contribution from covalent species-both disulfide and nondisulfide linked, while the HMW aggregate contained a higher percentage of molecules that had the peptide bond cleavage in the CH2 domain. The dimer formed at pH - 6.0 was found to have identical secondary and tertiary structure as the intact antibody molecule. However, the dimer and higher molecular weight aggregate formed at pH - 4.0 have altered secondary and tertiary structure.


Protein Science | 2007

Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain

Arnold McAuley; Jaby Jacob; Carl G. Kolvenbach; Kimberly Westland; Hyo Jin Lee; Stephen R. Brych; Douglas Rehder; Gerd R. Kleemann; David N. Brems; Masazumi Matsumura

Recombinant human monoclonal antibodies have become important protein‐based therapeutics for the treatment of various diseases. The antibody structure is complex, consisting of β‐sheet rich domains stabilized by multiple disulfide bridges. The dimerization of the CH3 domain in the constant region of the heavy chain plays a pivotal role in the assembly of an antibody. This domain contains a single buried, highly conserved disulfide bond. This disulfide bond was not required for dimerization, since a recombinant human CH3 domain, even in the reduced state, existed as a dimer. Spectroscopic analyses showed that the secondary and tertiary structures of reduced and oxidized CH3 dimer were similar, but differences were observed. The reduced CH3 dimer was less stable than the oxidized form to denaturation by guanidinium chloride (GdmCl), pH, or heat. Equilibrium sedimentation revealed that the reduced dimer dissociated at lower GdmCl concentration than the oxidized form. This implies that the disulfide bond shifts the monomer–dimer equilibrium. Interestingly, the dimer–monomer dissociation transition occurred at lower GdmCl concentration than the unfolding transition. Thus, disulfide bond formation in the human CH3 domain is important for stability and dimerization. Here we show the importance of the role played by the disulfide bond and how it affects the stability and monomer–dimer equilibrium of the human CH3 domain. Hence, these results may have implications for the stability of the intact antibody.


Journal of Pharmaceutical Sciences | 2013

The Identification of Free Cysteine Residues Within Antibodies a Potential Role for Free Cysteine Residues in Covalent Aggregation Because of Agitation Stress

Joon H. Huh; April J. White; Stephen R. Brych; Heather Franey; Masazumi Matsumura

Human immunoglobulin G1 (IgG1) and immunoglobulin G2 (IgG2) antibodies contain multiple disulfide bonds, which are an integral part of the structure and stability of the protein. Open disulfide bonds have been detected in a number of therapeutic and serum derived antibodies. This report details a method that fluorescently labels free cysteine residues, quantifies, and identifies the proteolytic fragments by liquid chromatography coupled to online mass spectrometry. The majority of the open disulfide bonds in recombinant and serum derived IgG1 and IgG2 antibodies were in the constant domains. This method was applied to the identification of cysteines in an IgG2 antibody that are involved in the formation of covalent intermolecular bonds because of the application of a severe agitation stress. The free cysteine in the CH 1 domain of the IgG2 decreased upon application of the stress and implicates open disulfide bonds in this domain as the likely source of free cysteines involved in the formation of intermolecular disulfide bonds. The presence of comparable levels of open disulfide bonds in recombinant and endogenous antibodies suggests that open disulfide bonds are an inherent feature of antibodies and that the susceptibility of intermolecular disulfide bond formation is similar for recombinant and serum-derived IgG antibodies.


Archive | 2007

Stable polypeptide formulations

Douglas Rehder; Pavel V. Bondarenko; Dirk Chelius; Arnold McAuley; Masazumi Matsumura


Archive | 2006

Formulations that inhibit protein aggregation

Stephen R. Brych; Masazumi Matsumura


Biomolecular Nmr Assignments | 2007

Assignment of 1H, 13C and 15N resonances of the reduced human IgG1 CH3 domain

Dingjiang Liu; Melanie J. Cocco; Masazumi Matsumura; Da Ren; Bridget Becker; Richard L. Remmele; David N. Brems


Archive | 2007

Immunoglobulin constant region domains with enhanced stability

Masazumi Matsumura; Jaby Jacob


Archive | 2013

RESEARCH ARTICLES Pharmaceutical Biotechnology The Identification of Free Cysteine Residues Within Antibodies and a Potential Role for Free Cysteine Residues in Covalent Aggregation Because of Agitation Stress

Joon H. Huh; April J. White; Stephen R. Brych; Heather Franey; Masazumi Matsumura


Biomolecular Nmr Assignments | 2007

Assignment of 1 H, 13 C and 15 N resonances of the reduced human IgG1

Dingjiang Liu; Melanie J. Cocco; Masazumi Matsumura; Da Ren; Bridget Becker; Richard L. Remmele; David N. Brems

Collaboration


Dive into the Masazumi Matsumura's collaboration.

Researchain Logo
Decentralizing Knowledge